NABH Aligned StandardsOPD: Mon–Sat 8:00 AM – 8:00 PM • Sun 9:00 AM – 2:00 PM
Super-Specialty Disease Protocols

Comprehensive Chronic
Diseases & Reversal Directory

Explore our evidence-based, physician-led clinical protocols for managing, stabilizing, and reversing chronic metabolic, cardiovascular, respiratory, renal, and musculoskeletal conditions.

CardiovascularReversible

High Blood Pressure (Hypertension)

I10 - Essential (primary) hypertension

Hypertension is a silent, progressive chronic condition where the force of blood against arterial walls remains persistently elevated (>= 130/80 mmHg), accelerating arterial stiffening, stroke, heart failure, and renal decline.

Prevalence in India

Affects over 31% of urban and 27% of rural adults in North India.

Target BP Range

< 120/80 mmHg

Stroke Risk Reduction

Up to 40%

Avg Pill Reduction

50-100% in Stage 1

Metabolic & EndocrineReversible

Type 2 Diabetes & Prediabetes

E11 - Type 2 diabetes mellitus

Type 2 Diabetes is primarily a disease of progressive insulin resistance and hepatic glucose overproduction. Our clinical reversal protocol restores beta-cell sensitivity and safely achieves HbA1c remission.

Prevalence in India

Over 101 million people in India are diabetic, with 136 million prediabetic.

Diabetes Remission Rate

78.4%

Avg HbA1c Drop

2.8% in 90 Days

Medication Cessation

65%+ of enrolled

Metabolic & EndocrineReversible

Thyroid Disorders (Hypo & Hyperthyroidism)

E03.9 - Hypothyroidism, unspecified

Thyroid dysfunction impairs metabolic rate, energy production, body temperature, and mood. We specialize in root-cause autoantibody assessment, T3/T4 conversion, and endocrine restoration.

Prevalence in India

1 in 8 Indian women suffers from thyroid dysfunction, predominantly hypothyroidism.

Autoimmune Identification

92% in Clinic

Energy Score Improvement

+85% in 60 Days

Optimal TSH Target

1.0 - 2.5 mIU/L

CardiovascularReversible

Heart Disease & Preventive Cardiology

I25.1 - Atherosclerotic heart disease

Coronary artery disease is driven by endothelial inflammation and arterial plaque. Our preventive cardiology program stabilizes plaque, improves ejection fraction, and reverses cardiovascular risk.

Prevalence in India

Indians develop CAD 10 years earlier than Western populations; 28% of all deaths in India.

Angina Free Rate

84% in 90 Days

ApoB Reduction Target

< 60 mg/dL

Exercise Capacity

+45% in 12 Weeks

Respiratory

COPD (Chronic Obstructive Pulmonary Disease)

J44.9 - Chronic obstructive pulmonary disease, unspecified

COPD is a progressive chronic lung disease causing restricted airflow, persistent cough, and dyspnea. Our pulmonary rehabilitation clinic maximizes lung capacity and prevents acute exacerbations.

Prevalence in India

Second leading cause of death in India; affects over 55 million Indians.

Flare-Up Reduction

75% in Enrolled

6-Min Walk Distance

+80 Meters in 8 Wks

Inhaler Technique Mastery

98% in Clinic

RespiratoryReversible

Chronic Bronchial Asthma

J45.9 - Asthma, unspecified

Asthma is a chronic inflammatory disorder of the airways causing hyper-responsiveness, wheezing, chest tightness, and nighttime cough. Our clinic achieves complete symptom control with minimal inhaler dosages.

Prevalence in India

Over 38 million asthma patients in India, accounting for 42% of global asthma deaths.

Nocturnal Attack Relief

94% in 30 Days

Emergency Room Avoidance

98% in Enrolled

GINA Guideline Adherence

100% Protocols

Renal & Kidney

Chronic Kidney Disease (Early Stages & Preservation)

N18.9 - Chronic kidney disease, unspecified

Early CKD is silent yet reversible or stabilizable. Our Renal Preservation Protocol protects nephrons, controls microalbuminuria, and delays or prevents dialysis.

Prevalence in India

Affects over 17% of the Indian population; major cause of end-stage morbidity.

Dialysis Delay / Prevention

95%+ in Early Stages

Proteinuria Reduction

50-70% in 90 Days

eGFR Stabilization Rate

91% in Enrolled

Digestive & HepaticReversible

Fatty Liver Disease (NAFLD / MASLD)

K76.0 - Fatty (change of) liver, not elsewhere classified

Fatty Liver is the hepatic manifestation of metabolic syndrome. Our targeted Hepatometabolic Protocol reverses liver fat, normalizes SGOT/SGPT, and halts fibrosis progression.

Prevalence in India

Affects over 38% of Indian adults, with over 55% prevalence in diabetic individuals.

Enzyme Normalization

89% in 8 Weeks

Liver Fat Reduction

Grade 2 -> Grade 0/1

Fibrosis Arrest Rate

96% in Enrolled

Musculoskeletal & JointReversible

Arthritis & Chronic Joint Care

M19.9 - Osteoarthritis, unspecified

Chronic joint pain and cartilage degeneration limit mobility and quality of life. Our non-surgical joint care program restores cartilage health, reduces systemic inflammation, and rebuilds joint mobility.

Prevalence in India

Over 180 million Indians suffer from arthritis; 1 in 4 elderly adults affected.

Surgery Avoidance Rate

82% in Mild/Mod

Pain Relief Score

-70% in 60 Days

Mobility Restoration

+60% Range of Motion

Metabolic & EndocrineReversible

Obesity & Metabolic Syndrome

E66.9 - Obesity, unspecified / E88.81 - Metabolic syndrome

Obesity is a complex hormonal and metabolic disorder driven by insulin resistance, leptin signaling failure, and chronic inflammation. Our medical weight loss protocol resets metabolism safely.

Prevalence in India

Affects over 30% of adult urban Indians; massive driver of premature cardiometabolic disease.

Avg Fat Loss

8-12 kg in 12 Wks

Metabolic Syndrome Reversal

82% in Enrolled

Muscle Mass Preservation

95%+ Retention

CardiovascularReversible

High Cholesterol & Dyslipidemia

E78.5 - Hyperlipidemia, unspecified

Dyslipidemia is an imbalance of atherogenic lipids in the bloodstream. We utilize advanced Apolipoprotein-B (ApoB) mapping and metabolic lipid balancing to eliminate arterial plaque risk.

Prevalence in India

Over 79% of urban Indians have at least one abnormal lipid parameter (high TG or low HDL).

ApoB Optimization

< 65 mg/dL Goal

Triglyceride Drop

-45% in 60 Days

Statin Intolerance Mgmt

98% Success

NeurologicalReversible

Chronic Migraine & Tension Headaches

G43.9 - Migraine, unspecified

Chronic migraine is a debilitating neurovascular disorder characterized by trigeminal sensitization and cortical spreading depression. Our protocol achieves lasting attack reduction without overusing painkillers.

Prevalence in India

Affects over 213 million Indians; #1 cause of disability in individuals aged 15-49.

Attack Frequency Drop

-75% in 8 Weeks

Painkiller De-Escalation

92% Success Rate

Symptom-Free Days

24+ Days/Month Goal

Musculoskeletal & JointReversible

Osteoporosis & Bone Health

M81.0 - Age-related osteoporosis without current pathological fracture

Osteoporosis is a silent skeletal disease characterized by low bone mass and structural micro-architectural deterioration. Our Bone Mineralization Protocol restores bone density and prevents fragility fractures.

Prevalence in India

Over 50 million Indians have osteoporosis or severely low bone mass (osteopenia).

Fracture Risk Reduction

Up to 70%

T-Score Improvement

Documented on DEXA

Fall Prevention Rate

90% in Protocol

Hormonal & Women's HealthReversible

PCOS / PCOD (Polycystic Ovary Syndrome)

E28.2 - Polycystic ovarian syndrome

PCOS is a neuro-endocrine and metabolic condition driven by insulin resistance, hyperandrogenism, and chronic inflammation. Our Holistic Metabolic Protocol restores regular cycles, clears acne/hirsutism, and restores fertility.

Prevalence in India

Affects 1 in 5 Indian women of reproductive age; rapidly rising in urban centers.

Natural Cycle Restoration

88% in 6 Months

Insulin Sensitivity Boost

+75% in 90 Days

Acne & Hirsutism Relief

80% Documented

Metabolic & EndocrineReversible

Chronic Anemia & Nutritional Deficiencies

D50.9 - Iron deficiency anemia, unspecified

Chronic anemia deprives vital organs of oxygen, causing chronic exhaustion, dizziness, and cognitive decline. Our Hematology & Nutrient Optimization Clinic restores hemoglobin and tissue iron stores.

Prevalence in India

Affects over 57% of Indian women and 25% of men (NFHS-5 data).

Hemoglobin Normalization

94% in 60 Days

Ferritin Target Reached

> 50 ng/mL Goal

Energy Score Surge

+90% in Enrolled

NeurologicalReversible

Sleep Apnea & Chronic Sleep Disorders

G47.33 - Obstructive sleep apnea (adult) (pediatric)

Obstructive Sleep Apnea causes nocturnal airway collapse, severe oxygen desaturation, and morning cardiovascular surges. Our Sleep Medicine Clinic restores deep restorative sleep architecture.

Prevalence in India

Affects over 104 million Indians, with over 80% remaining undiagnosed and untreated.

Daytime Alertness Surge

95% in 7 Days

Nighttime BP Normalization

10-15 mmHg Drop

Apnea-Hypopnea Index (AHI)

< 5 Normal Goal

Not Sure Which Protocol Fits Your Symptoms?

Take our 1-minute confidential screener to determine your cardiometabolic risk and recommended investigations.

1-Minute Chronic Health Risk Screener

Evidence-based assessment for Diabetes, Hypertension & Metabolic Risk

Question 1 of 5
Metabolic Risk

What is your current age bracket?

Common Questions

Chronic Care FAQs

Standard medical practice often focuses on symptom suppression—prescribing lifelong pills and continuously increasing dosages as the condition deteriorates. At Haryana Hospital, we practice Root-Cause Metabolic Medicine: identifying and reversing cellular insulin resistance, chronic endothelial stiffness, ectopic organ fat, and gut-immune inflammation to restore organ function and safely taper or eliminate medication dependency.

Call OPDWhatsAppBook Now